Logo image of GPRE

GREEN PLAINS INC (GPRE) Stock Fundamental Analysis

NASDAQ:GPRE - Nasdaq - US3932221043 - Common Stock - Currency: USD

7.89  -0.03 (-0.38%)

After market: 7.91 +0.02 (+0.25%)

Fundamental Rating

2

Overall GPRE gets a fundamental rating of 2 out of 10. We evaluated GPRE against 210 industry peers in the Oil, Gas & Consumable Fuels industry. GPRE has a bad profitability rating. Also its financial health evaluation is rather negative. GPRE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year GPRE has reported negative net income.
In the past year GPRE has reported a negative cash flow from operations.
GPRE had negative earnings in each of the past 5 years.
GPRE had a positive operating cash flow in 4 of the past 5 years.
GPRE Yearly Net Income VS EBIT VS OCF VS FCFGPRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

With a Return On Assets value of -6.24%, GPRE is not doing good in the industry: 79.05% of the companies in the same industry are doing better.
With a Return On Equity value of -13.04%, GPRE is not doing good in the industry: 74.76% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -6.24%
ROE -13.04%
ROIC N/A
ROA(3y)-5.15%
ROA(5y)-5.08%
ROE(3y)-11.53%
ROE(5y)-11.67%
ROIC(3y)N/A
ROIC(5y)N/A
GPRE Yearly ROA, ROE, ROICGPRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15 -20

1.3 Margins

Looking at the Gross Margin, with a value of 5.19%, GPRE is doing worse than 75.71% of the companies in the same industry.
GPRE's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for GPRE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.46%
GM growth 5Y30.95%
GPRE Yearly Profit, Operating, Gross MarginsGPRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

More info and screens

1

2. Health

2.1 Basic Checks

GPRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GPRE has more shares outstanding
The number of shares outstanding for GPRE has been increased compared to 5 years ago.
The debt/assets ratio for GPRE is higher compared to a year ago.
GPRE Yearly Shares OutstandingGPRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
GPRE Yearly Total Debt VS Total AssetsGPRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

GPRE has an Altman-Z score of 1.44. This is a bad value and indicates that GPRE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of GPRE (1.44) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.71 indicates that GPRE is somewhat dependend on debt financing.
GPRE's Debt to Equity ratio of 0.71 is on the low side compared to the rest of the industry. GPRE is outperformed by 61.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Altman-Z 1.44
ROIC/WACCN/A
WACC8.62%
GPRE Yearly LT Debt VS Equity VS FCFGPRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

2.3 Liquidity

GPRE has a Current Ratio of 1.38. This is a normal value and indicates that GPRE is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.38, GPRE is doing good in the industry, outperforming 64.29% of the companies in the same industry.
GPRE has a Quick Ratio of 1.38. This is a bad value and indicates that GPRE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of GPRE (0.81) is worse than 61.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.81
GPRE Yearly Current Assets VS Current LiabilitesGPRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

The earnings per share for GPRE have decreased strongly by -37.40% in the last year.
GPRE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.51%.
Measured over the past years, GPRE shows a small growth in Revenue. The Revenue has been growing by 0.34% on average per year.
EPS 1Y (TTM)-37.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40.74%
Revenue 1Y (TTM)-19.51%
Revenue growth 3Y-4.55%
Revenue growth 5Y0.34%
Sales Q2Q%0.72%

3.2 Future

GPRE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 57.49% yearly.
Based on estimates for the next years, GPRE will show a quite strong growth in Revenue. The Revenue will grow by 8.70% on average per year.
EPS Next Y-10.5%
EPS Next 2Y44.91%
EPS Next 3Y42.11%
EPS Next 5Y57.49%
Revenue Next Year-2%
Revenue Next 2Y0.43%
Revenue Next 3Y8.55%
Revenue Next 5Y8.7%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GPRE Yearly Revenue VS EstimatesGPRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
GPRE Yearly EPS VS EstimatesGPRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 5 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

GPRE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 58.02, GPRE can be considered very expensive at the moment.
69.05% of the companies in the same industry are cheaper than GPRE, based on the Price/Forward Earnings ratio.
GPRE is valuated expensively when we compare the Price/Forward Earnings ratio to 35.33, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 58.02
GPRE Price Earnings VS Forward Price EarningsGPRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GPRE is valued a bit more expensive than the industry average as 73.81% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 78.42
GPRE Per share dataGPRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

GPRE's earnings are expected to grow with 42.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.91%
EPS Next 3Y42.11%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GPRE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GREEN PLAINS INC

NASDAQ:GPRE (7/15/2025, 8:00:01 PM)

After market: 7.91 +0.02 (+0.25%)

7.89

-0.03 (-0.38%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners91.59%
Inst Owner Change0%
Ins Owners1%
Ins Owner Change6.39%
Market Cap516.01M
Analysts72
Price Target8.8 (11.53%)
Short Float %14.21%
Short Ratio5.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.08
Dividend Growth(5Y)-36.76%
DP-4.97%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-133.26%
Min EPS beat(2)-165.14%
Max EPS beat(2)-101.38%
EPS beat(4)1
Avg EPS beat(4)-29.33%
Min EPS beat(4)-213.36%
Max EPS beat(4)362.54%
EPS beat(8)2
Avg EPS beat(8)-968.52%
EPS beat(12)3
Avg EPS beat(12)-729.5%
EPS beat(16)4
Avg EPS beat(16)-588.94%
Revenue beat(2)0
Avg Revenue beat(2)-5.86%
Min Revenue beat(2)-9.38%
Max Revenue beat(2)-2.34%
Revenue beat(4)0
Avg Revenue beat(4)-5.2%
Min Revenue beat(4)-9.38%
Max Revenue beat(4)-2.34%
Revenue beat(8)2
Avg Revenue beat(8)-3.87%
Revenue beat(12)5
Avg Revenue beat(12)-1.6%
Revenue beat(16)9
Avg Revenue beat(16)0.05%
PT rev (1m)0%
PT rev (3m)-22.37%
EPS NQ rev (1m)-0.48%
EPS NQ rev (3m)-15.38%
EPS NY rev (1m)-41.53%
EPS NY rev (3m)-90.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.02%
Revenue NY rev (1m)-1.07%
Revenue NY rev (3m)-2.61%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 58.02
P/S 0.21
P/FCF N/A
P/OCF N/A
P/B 0.65
P/tB 0.65
EV/EBITDA 78.42
EPS(TTM)-1.69
EYN/A
EPS(NY)0.14
Fwd EY1.72%
FCF(TTM)-1.9
FCFYN/A
OCF(TTM)-0.53
OCFYN/A
SpS37.66
BVpS12.19
TBVpS12.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.24%
ROE -13.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.19%
FCFM N/A
ROA(3y)-5.15%
ROA(5y)-5.08%
ROE(3y)-11.53%
ROE(5y)-11.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.46%
GM growth 5Y30.95%
F-Score2
Asset Turnover1.48
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Debt/EBITDA 52.45
Cap/Depr 98.37%
Cap/Sales 3.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.38
Quick Ratio 0.81
Altman-Z 1.44
F-Score2
WACC8.62%
ROIC/WACCN/A
Cap/Depr(3y)148.04%
Cap/Depr(5y)157.81%
Cap/Sales(3y)4.32%
Cap/Sales(5y)5.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40.74%
EPS Next Y-10.5%
EPS Next 2Y44.91%
EPS Next 3Y42.11%
EPS Next 5Y57.49%
Revenue 1Y (TTM)-19.51%
Revenue growth 3Y-4.55%
Revenue growth 5Y0.34%
Sales Q2Q%0.72%
Revenue Next Year-2%
Revenue Next 2Y0.43%
Revenue Next 3Y8.55%
Revenue Next 5Y8.7%
EBIT growth 1Y-45.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year172.98%
EBIT Next 3Y71.18%
EBIT Next 5Y62.64%
FCF growth 1Y-83.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-129.87%
OCF growth 3YN/A
OCF growth 5YN/A